BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8626540)

  • 1. Expression of the three alternative forms of the sphingolipid activator protein precursor in baby hamster kidney cells and functional assays in a cell culture system.
    Henseler M; Klein A; Glombitza GJ; Suziki K; Sandhoff K
    J Biol Chem; 1996 Apr; 271(14):8416-23. PubMed ID: 8626540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of a splice-site mutation in the sap-precursor gene of a patient with metachromatic leukodystrophy.
    Henseler M; Klein A; Reber M; Vanier MT; Landrieu P; Sandhoff K
    Am J Hum Genet; 1996 Jan; 58(1):65-74. PubMed ID: 8554069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiological relevance of sphingolipid activator proteins in cultured human fibroblasts.
    Sadeghlar F; Remmel N; Breiden B; Klingenstein R; Schwarzmann G; Sandhoff K
    Biochimie; 2003; 85(3-4):439-48. PubMed ID: 12770782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accumulation of sphingolipids in SAP-precursor (prosaposin)-deficient fibroblasts occurs as intralysosomal membrane structures and can be completely reversed by treatment with human SAP-precursor.
    Burkhardt JK; Hüttler S; Klein A; Möbius W; Habermann A; Griffiths G; Sandhoff K
    Eur J Cell Biol; 1997 May; 73(1):10-8. PubMed ID: 9174667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A non-glycosylated and functionally deficient mutant (N215H) of the sphingolipid activator protein B (SAP-B) in a novel case of metachromatic leukodystrophy (MLD).
    Wrobe D; Henseler M; Huettler S; Pascual Pascual SI; Chabas A; Sandhoff K
    J Inherit Metab Dis; 2000 Feb; 23(1):63-76. PubMed ID: 10682309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biosynthesis, processing, and targeting of sphingolipid activator protein (SAP )precursor in cultured human fibroblasts. Mannose 6-phosphate receptor-independent endocytosis of SAP precursor.
    Vielhaber G; Hurwitz R; Sandhoff K
    J Biol Chem; 1996 Dec; 271(50):32438-46. PubMed ID: 8943309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additional biochemical findings in a patient and fetal sibling with a genetic defect in the sphingolipid activator protein (SAP) precursor, prosaposin. Evidence for a deficiency in SAP-1 and for a normal lysosomal neuraminidase.
    Paton BC; Schmid B; Kustermann-Kuhn B; Poulos A; Harzer K
    Biochem J; 1992 Jul; 285 ( Pt 2)(Pt 2):481-8. PubMed ID: 1637339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sphingolipid activator protein D (sap-D) stimulates the lysosomal degradation of ceramide in vivo.
    Klein A; Henseler M; Klein C; Suzuki K; Harzer K; Sandhoff K
    Biochem Biophys Res Commun; 1994 May; 200(3):1440-8. PubMed ID: 8185598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of human saposin B sphingolipid-binding specificity by alternative splicing. A study with saposin B-derived synthetic peptides.
    Lamontagne S; Potier M
    J Biol Chem; 1994 Aug; 269(32):20528-32. PubMed ID: 8051151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation, characterization, and proteolysis of human prosaposin, the precursor of saposins (sphingolipid activator proteins).
    Hiraiwa M; O'Brien JS; Kishimoto Y; Galdzicka M; Fluharty AL; Ginns EI; Martin BM
    Arch Biochem Biophys; 1993 Jul; 304(1):110-6. PubMed ID: 8323276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biosynthesis of the sulfatide/GM1 activator protein (SAP-1) in control and mutant cultured skin fibroblasts.
    Fujibayashi S; Wenger DA
    Biochim Biophys Acta; 1986 Feb; 875(3):554-62. PubMed ID: 3081038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Degradation of membrane-bound ganglioside GM1. Stimulation by bis(monoacylglycero)phosphate and the activator proteins SAP-B and GM2-AP.
    Wilkening G; Linke T; Uhlhorn-Dierks G; Sandhoff K
    J Biol Chem; 2000 Nov; 275(46):35814-9. PubMed ID: 10942779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Saposin C mutations in Gaucher disease patients resulting in lysosomal lipid accumulation, saposin C deficiency, but normal prosaposin processing and sorting.
    Vaccaro AM; Motta M; Tatti M; Scarpa S; Masuelli L; Bhat M; Vanier MT; Tylki-Szymanska A; Salvioli R
    Hum Mol Genet; 2010 Aug; 19(15):2987-97. PubMed ID: 20484222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrolysis of lactosylceramide by human galactosylceramidase and GM1-beta-galactosidase in a detergent-free system and its stimulation by sphingolipid activator proteins, sap-B and sap-C. Activator proteins stimulate lactosylceramide hydrolysis.
    Zschoche A; Fürst W; Schwarzmann G; Sanhoff K
    Eur J Biochem; 1994 May; 222(1):83-90. PubMed ID: 8200356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a mutation in a family with saposin B deficiency: a glycosylation site defect.
    Kretz KA; Carson GS; Morimoto S; Kishimoto Y; Fluharty AL; O'Brien JS
    Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2541-4. PubMed ID: 2320574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Only sphingolipid activator protein B (SAP-B or saposin B) stimulates the degradation of globotriaosylceramide by recombinant human lysosomal alpha-galactosidase in a detergent-free liposomal system.
    Kase R; Bierfreund U; Klein A; Kolter T; Itoh K; Suzuki M; Hashimoto Y; Sandhoff K; Sakuraba H
    FEBS Lett; 1996 Sep; 393(1):74-6. PubMed ID: 8804427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Processing of sphingolipid activator proteins and the topology of lysosomal digestion.
    Sandhoff K; Kolter T
    Acta Biochim Pol; 1998; 45(2):373-84. PubMed ID: 9821868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction of sulfatide metabolism after transfer of prosaposin cDNA to cultured cells from a patient with SAP-1 deficiency.
    Rafi MA; Amini S; Zhang XL; Wenger DA
    Am J Hum Genet; 1992 Jun; 50(6):1252-8. PubMed ID: 1350885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous deficiency of sphingolipid activator proteins 1 and 2 is caused by a mutation in the initiation codon of their common gene.
    Schnabel D; Schröder M; Fürst W; Klein A; Hurwitz R; Zenk T; Weber J; Harzer K; Paton BC; Poulos A
    J Biol Chem; 1992 Feb; 267(5):3312-5. PubMed ID: 1371116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted disruption of the mouse sphingolipid activator protein gene: a complex phenotype, including severe leukodystrophy and wide-spread storage of multiple sphingolipids.
    Fujita N; Suzuki K; Vanier MT; Popko B; Maeda N; Klein A; Henseler M; Sandhoff K; Nakayasu H; Suzuki K
    Hum Mol Genet; 1996 Jun; 5(6):711-25. PubMed ID: 8776585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.